AVANIR PHARMACEUTICALS INC's ticker is and the CUSIP is 05348P40. A total of 2 filers reported holding AVANIR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $12,849,000 | -64.1% | 758,055 | -74.8% | 0.74% | -61.4% |
Q3 2014 | $35,839,000 | -38.3% | 3,006,682 | -70.8% | 1.93% | -32.4% |
Q2 2014 | $58,058,000 | +42.7% | 10,294,143 | -7.1% | 2.85% | +30.9% |
Q1 2014 | $40,679,000 | +8.4% | 11,084,443 | -0.8% | 2.18% | +5.4% |
Q4 2013 | $37,534,000 | -20.5% | 11,170,891 | +0.1% | 2.07% | -26.7% |
Q3 2013 | $47,184,000 | -8.6% | 11,154,701 | -0.6% | 2.82% | -14.2% |
Q2 2013 | $51,611,000 | – | 11,219,880 | – | 3.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 11,084,443 | $40,679,000 | 2.18% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 42,537 | $156,000 | 0.00% |